Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Differentiated CaCo-2 cells as an in-vitro model to evaluate de-novo apolipoprotein A-I production in the small intestine.

Dullens SP, Mensink RP, Mariman EC, Plat J.

Eur J Gastroenterol Hepatol. 2009 Jun;21(6):642-9.

PMID:
19445040
2.

Dietary oxidized fatty acids may enhance intestinal apolipoprotein A-I production.

Rong R, Ramachandran S, Penumetcha M, Khan N, Parthasarathy S.

J Lipid Res. 2002 Apr;43(4):557-64.

3.

Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mice.

Dullens SP, Mensink RP, Bragt MC, Kies AK, Plat J.

J Lipid Res. 2008 Apr;49(4):790-6. Epub 2007 Dec 27.

4.

Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.

Qin S, Liu T, Kamanna VS, Kashyap ML.

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2428-34. Epub 2007 Sep 13.

5.
6.

Increasing apoA-I production as a target for CHD risk reduction.

Dullens SP, Plat J, Mensink RP.

Nutr Metab Cardiovasc Dis. 2007 Oct;17(8):616-28. Epub 2007 Aug 20. Review.

PMID:
17703927
7.
8.

Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response.

Hennuyer N, Poulain P, Madsen L, Berge RK, Houdebine LM, Branellec D, Fruchart JC, Fiévet C, Duverger N, Staels B.

Circulation. 1999 May 11;99(18):2445-51.

9.

Differential tissue-specific expression of human apoA-I and apoA-II.

Eggerman TL, Hoeg JM, Meng MS, Tombragel A, Bojanovski D, Brewer HB Jr.

J Lipid Res. 1991 May;32(5):821-8.

12.

Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells.

Siripurkpong P, Na-Bangchang K.

J Nutr Biochem. 2009 Apr;20(4):261-8. doi: 10.1016/j.jnutbio.2008.02.010. Epub 2008 Jul 7.

PMID:
18602814
13.

The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates.

Vu-Dac N, Chopin-Delannoy S, Gervois P, Bonnelye E, Martin G, Fruchart JC, Laudet V, Staels B.

J Biol Chem. 1998 Oct 2;273(40):25713-20.

14.

Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme.

Barbier O, Duran-Sandoval D, Pineda-Torra I, Kosykh V, Fruchart JC, Staels B.

J Biol Chem. 2003 Aug 29;278(35):32852-60. Epub 2003 Jun 16.

15.

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.

Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Fruchart JC, Staels B, Auwerx J.

J Clin Invest. 1995 Aug;96(2):741-50.

16.

Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.

Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, Auwerx J.

J Biol Chem. 1997 Oct 24;272(43):27307-12.

18.

Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.

Kim MJ, Deplewski D, Ciletti N, Michel S, Reichert U, Rosenfield RL.

Mol Genet Metab. 2001 Nov;74(3):362-9.

PMID:
11708867
19.

Supplemental Content

Support Center